Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tadalafil Effect + Chemotherapy in Patients With Resectable Gastric/GEJ Adenocarcinoma
NCT05709574Phase 2Active, not recruiting
- Sponsor
- University of Arizona
- Start
- Apr 2023
- Primary completion
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tadalafil in gastric adenocarcinoma, gastroesophageal junction adenocarcinoma, sponsored by University of Arizona. Started Apr 2023; status: active, not recruiting.
02
Drugs
tadalafil
03
Conditions
gastric adenocarcinomagastroesophageal junction adenocarcinoma
Beyond the preview
Go deeper on NCT05709574.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05709574.